Literature DB >> 18432838

51Cr release assay of antibody-dependent cell-mediated cytotoxicity (ADCC).

D L Nelson1, C C Kurman, D E Serbousek.   

Abstract

Antibody-dependent cell-mediated cytotoxicity (ADCC) is an immunologic cytotoxic effector mechanism that is dependent on the cooperative interaction of humoral and cellular effector elements. This unit describes an assay of ADCC activity that can be used as a test for immunocompetence in effector cells or to test the activity of a monoclonal antibody to mediate ADCC. In this form of cytotoxicity, effector cells with receptors for the Fc portion of immunoglobulin produce target cell lysis by attachment to the Fc portion of antibodies that are bound to target cells via their antigen-combining sites. Therefore, an ADCC assay involves three essential components: labeled target cells, antibodies with specificity for target-cell surface antigens, and effector-cell populations. The basic protocol describes a method of measuring ADCC effector activity in lymphoid cells (peripheral blood mononuclear cells, or PBMC) that employs (51)Cr-labeled target cells. The three components are mixed in microtiter-plate wells and lysis of the target cells is detected by measuring the release of radioactivity into the cell supernatant. Support protocols describe procedures for preparing anti-target cell antiserum and (51)Cr-labeled target cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432838     DOI: 10.1002/0471142735.im0727s08

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  7 in total

1.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.

Authors:  Yuting Hong; Huilin Guo; Min Wei; Yali Zhang; Mujin Fang; Tong Cheng; Zhiyong Li; Shengxiang Ge; Xiangyang Yao; Quan Yuan; Ningshao Xia
Journal:  J Virol Methods       Date:  2022-06-06       Impact factor: 2.623

3.  A simple and sensitive method for measuring tumor-specific T cell cytotoxicity.

Authors:  Xinping Fu; Lihua Tao; Armando Rivera; Shana Williamson; Xiao-Tong Song; Nabil Ahmed; Xiaoliu Zhang
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

4.  Development of a cell-based assay measuring the activation of FcγRIIa for the characterization of therapeutic monoclonal antibodies.

Authors:  Minoru Tada; Akiko Ishii-Watabe; Takuo Suzuki; Nana Kawasaki
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  In vitro immunotherapy potency assays using real-time cell analysis.

Authors:  Fabio Cerignoli; Yama A Abassi; Brandon J Lamarche; Garret Guenther; David Santa Ana; Diana Guimet; Wen Zhang; Jing Zhang; Biao Xi
Journal:  PLoS One       Date:  2018-03-02       Impact factor: 3.240

6.  A multivariate, quantitative assay that disentangles key kinetic parameters of primary human T cell function in vitro.

Authors:  Grace L Huang; Daniel P Nampe; Jason Yi; Grant B Gabrelow; Kathleen R Negri; Alexander Kamb; Han Xu
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

7.  Development of a Macrophage-Based ADCC Assay.

Authors:  Melissa B Uccellini; Sadaf Aslam; Sean T H Liu; Fahmida Alam; Adolfo García-Sastre
Journal:  Vaccines (Basel)       Date:  2021-06-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.